We are live on ! Find out more
MITO

Stealth BioTherapeutics Corp. ADS
MITO

Delisted

MITO was delisted on the 15th of November, 2022.

Back to rankings

10 hedge funds and large institutions have $835K invested in Stealth BioTherapeutics Corp. ADS in 2020 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

11% more funds holding

Funds holding: 9 → 10 (+1)

45% less capital invested

Capital invested by funds: $1.53M → $835K (-$697K)

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
10
Holders Change
+1
Holders Change %
+11.11%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$20.9K
2
HF
HRT Financial
New York
+$5.72K
3
Osaic Holdings
Osaic Holdings
Arizona
+$1.03K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$285K
2
PM
Prosight Management
Texas
-$60.1K
3
Millennium Management
Millennium Management
New York
-$40K
4
UBS Group
UBS Group
Switzerland
-$12.3K
5
PC
PA Capital
Virginia
-$7.9K

MITO Hedge Fund Activity: Q3 2020 in Review

10 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Stealth BioTherapeutics Corp. ADS (MITO) for Q3 2020, worth a combined $835K — down 45% from $1.53M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new MITO positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 4 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $20.9K. The largest seller was Renaissance Technologies, cutting an estimated $285K.

  • 10 institutional investors held Stealth BioTherapeutics Corp. ADS (MITO) as of Q3 2020, up from 9 in Q2 2020.
  • Funds reported $835K of Stealth BioTherapeutics Corp. ADS stock for Q3 2020, down 45% quarter-over-quarter.
  • 2 funds opened new Stealth BioTherapeutics Corp. ADS positions in Q3 2020 and 1 closed out, a net change of +1 holder.
  • The largest Stealth BioTherapeutics Corp. ADS buyer in Q3 2020 was Citadel Advisors, an estimated $20.9K added.
  • The largest Stealth BioTherapeutics Corp. ADS seller in Q3 2020 was Renaissance Technologies, an estimated $285K sold.

Based on aggregated 13F filings for Q3 2020.